Abstract: A series of 2-amino-5-(4-(benzyloxy)benzyl)thiophene-3-carboxylic acid derivatives was designed and synthesized. The derivatives were evaluated for antitubercular activity against M. tuberculosis ATCC 27294 using the Microplate Alamar Blue Assay (MABA). Among them, compound 8b exhibited the most potent activity with MIC value of 1.9 PM.
INTRODUCTION
Tuberculosis (TB), a highly contagious and air-borne disease caused by Mycobacterium tuberculosis (Mtb), emerged with multi-drug resistant strains (MDR-TB) and acquired immune deficiency syndrome (AIDS) in recent years [1, 2] . The 2013 World Health Organization (WHO) global tuberculosis report estimated that nearly 1.5 million people died from TB every year in some developing countries [3] . In spite of the increasing worldwide incidences of TB, only bedaquiline (BDQ) has been approved for the treatment of MDR-TB since the introduction of rifampin in 1971 [4, 5] . Therefore, it is an imperative to develop novel antitubercular drugs that can be equally effective against M. tuberculosis and MDR-TB, and also reduce the duration of therapy.
Our research group has recently disclosed several series of heterocyclic such as thiophene, thiazole, oxazole and imidazole derivatives as potent antitubercular agents [6, 7] . Among them, the 5-phenyl thiophene derivatives displayed potent anti-tubercular activity [6] . In continuation of our research efforts to develop new therapeutics for treatment of TB, we envisioned the replacement of the 5-phenyl on thiophene by benzyl to provide the new derivatives, which were predicted to be closer to hydrophobic catalytic triad Cys112-His244-Asn274 of mtFabH ( Fig. 1) [8, 9] . The previous studied structure-activity relationships (SARs) suggested that the 2-acylated and 2-alkylated compounds with pchlorobenzoyl substituent or three to four atom alkyls showed the best antitubercular activity, respectively [6] . Accordingly, with the aim to further explore the SARs of designed compounds, which are presumed to be fundamental for antitubercular activity, a series of 2-acylated and 2-alkylated amino-5-(4-(benzyloxy)benzyl)thiophene-3-carboxylic acid derivatives (8a-h, and 10a-c) was synthesized and evaluated for their antitubercular activity.
MATERIALS AND METHODS

General Procedures
Melting points were determined on a Mel-TEMP II melting point apparatus and are uncorrected. Infrared (IR) spectra (KBr) were recorded on a Nicolet Impact 410 instrument (KBr pellet). 1 H NMR spectra were recorded with a Bruker Avance 300 MHz spectrometer at 300 K, using TMS as an internal standard. Chemical shifts are expressed in parts per million (ppm, units). Coupling constants are in units of hertz (Hz). The spin multiplicities are indicated by the symbols s (singlet), d (doublet), dd (doublet of doublets), t (triplet), q (quartet), m (multiplet), and br (broad). MS spectra were recorded on a Shimadzu GC-MS 2010 (EI) or a Mariner Mass Spectrum (ESI). Elemental analyses (C, H, N) were determined on Carlo Erba 1106 elementary analysis apparatus and were within ± 0.5% of the theoretical values. TLCs and preparative thin-layer chromatography were performed on silica gel GF/UV 254, and the chromatograms were performed on silica gel (100-200 mesh) visualized under UV light at 254 nm and 365 nm. All solvents were of reagent grade and, when necessary, were purified and dried by standard methods. Concentration of solutions after reactions and extractions involved the use of a rotary evaporator operating at a reduced pressure of ca. 20 Torr. Organic solutions were dried over anhydrous sodium sulfate.
Synthesis of Methyl 3-(4-(2,6-dichlorobenzyloxy)-phenyl)propanoate 3
To a solution of methyl 3-(4-hydroxyphenyl)propanoate 2 (18 g, 0.1 mol) and K 2 CO 3 (20.7 g, 0.15 mol) in acetone (200 mL), 2, 6-dichlorobenzyl chloride 1 (19.6 g, 0.1 mol) was added. The mixture was stirred vigorously, and heated to reflux for 24 h. On cooling the reaction mixture down to room temperature, the mixture was concentrated and diluted with water (200 mL) and then extracted with AcOEt (2 x 100 mL). The organic layers were washed with 10% NaOH solution, dried with Na 2 SO 4 
Synthesis of 3-(4-(2,6-dichlorobenzyloxy)phenyl)-propan-1-ol 4
The solution of methyl 3-(4-(2,6-dichlorobenzyloxy)-phenyl)propanoate 3 (13.54 g, 0.04 mol) in THF (40 mL) was added dropwise to a suspension of NaBH 4 (3.8 g, 0.1 mol) in THF (40 mL). After cooling to ambient temperature, a solution of I 2 (5.06 g, 0.02 mol) in THF (40 mL) was also added dropwise to the reaction mixture. The reaction mixture was heated to reflux for 12h. Another potion of I 2 (2.5 g, 0.01 mol) in THF (20 mL) was added dropwise to the reaction mixture before cooling to room temperature. The reaction mixture was diluted with AcOEt (50 mL) and 1N HCl (50 mL). The mixture was filtered and insoluble material was washed with AcOEt. The filtrate was extracted with AcOEt (2 x 50 mL). The combined organic layers was washed with H 2 O and saturated brine, and dried with Na 2 SO 4 . The solvent was concentrated in vacuo to afford 4 (11.3 g, 91.13%) as a yellow oil. 1 
Synthesis of 3-(4-(2,6-dichlorobenzyloxy)phenyl)-propanal 5
A solution of 3-(4-(2,6-dichlorobenzyloxy)phenyl)-propan-1-ol 4 (10.3 g, 0.033 mol) in dichloromethane (50 mL) was added to a stirred suspension of pyridinium chlorochromate (12 g, 0.05 mol) in dichloromethane (20 mL). The mixture was stirred for 2 hours at room temperature then filtered through a kieselguhr pad. The residue was washed with dichlorochromate (2 x 50 mL) and the combined organic layers were evaporated under reduced pressure. The residual oil was purified by column chromatography using petroleum ether: ethyl acetate (10:1) as eluent, yielding 5 (7.45 g, 73.32 %) as a yellow oil. 1 
Synthesis of Ethyl 5-(4-(2,6-dichlorobenzyloxy)-benzyl)-2-aminothiophene-3-carboxylate 6
Triethylamine (1.22 g, 0.0121 mol) was added to a vigorously stirred mixture of ethylcyanoacetate (2.73 g, 0.0242 mol), sulfur powder (0.77 g, 0.0242 mol) and DMF (40 mL). A solution of 3-(4-(2,6-dichlorobenzyloxy)phenyl)propanal 5 (7.45 g, 0.0242 mol) in DMF (40 mL) was added dropwise to this suspension, while maintaining the temperature at 50 °C. When the addition was complete, the reaction mixture was allowed to cool to room temperature and then stirred for 2 hours. The suspension was diluted with water (200 mL) and then extracted with AcOEt (2 x 100 mL). The combined organic layers were washed with water (2 x 100 mL), dried over anhydrous sodium sulfate, and concentrated under reduced pressure to afford yellow oil. The residue was purified by column chromatography using petroleum ether: ethyl acetate (10:1) as eluent, yielding 6 (6.01 g, 57.67%) as a yellow solid. Mp: 124-126 °C (dec). A mixture of benzoic acid (0.67 g, 0.0055 mol) in thionyl chloride (5 mL) was stirred under refluxed for 2h. After cooling to room temperature, the mixture was concentrated in vacuo to give crude product benzoyl chloride as a brown oil, which was dissolved in dry CH 2 Cl 2 (10 mL) without further purification. To a mixture of 6 (0.8 g, 0.00184 mol), dry triethylamine (3 mL) and dry dichloromethane (10 mL), the solution of benzoyl chloride in dry dichloromethane (10 mL) previously prepared was added. The whole mixture was stirred for overnight at room temperature. Water was added to the mixture and extracted with dichloromethane (2 x 15 mL). The combined organic layers were washed with saturated brine and dried with Na 2 SO 4 , then concentrated in vacuo. Purification of the crude products by column chromatography eluting with petroleum-ethyl acetate (6:1) gave 7a 
Ethyl 5-(4-(2,6-dichlorobenzyloxy)benzyl)-2-(4-chlorobenzamido)thiophene-3-carboxylate (7b)
By using 4-chlorobenzoic acid (1.24 g, 0.008 mol), thionyl chloride (10 mL), and 6 (0.87 g, 0.002 mol) according to the procedure that was used to prepare 7a, 7b (0.40 g, 35.09%) was obtained as a white solid. 
Ethyl 5-(4-(2,6-dichlorobenzyloxy)benzyl)-2-(2-fluorobenzamido)thiophene-3-carboxylate (7c)
To a mixture of 6 (0.86 g, 0.002 mol), dry triethylamine (3 mL) and dry dichloromethane (20 mL), the solution of 2-fluorobenzoyl chloride (0.63 g, 0.004 mol) in dry dichloromethane (20 mL) was added. The whole mixture was stirred for overnight at room temperature. Water was added to the mixture and extracted with dichloromethane (25 mL x 2). The combined organic layers were washed with brine and dried with Na 2 SO 4 , then concentrated in vacuo. Purification of the crude products by column chromatography eluting with petroleum-ethyl acetate (6:1) gave 7c (0.84 g, 76.36%) as a yellow solid. Mp 126-128 °C. 
Ethyl 5-(4-(2,6-dichlorobenzyloxy)benzyl)-2-(2-methoxybenzamido)thiophene-3-carboxylate (7d)
By using 2-methoxybenzoic acid (1.18 g, 0.008 mol), thionyl chloride (10 mL), and 6 (0.87 g, 0.002 mol) according to the procedure that was used to prepare 7a, 7d ( 
Ethyl 5-(4-(2,6-dichlorobenzyloxy)benzyl)-2-(4-methoxybenzamido)thiophene-3-carboxylate (7e)
By using 4-methoxybenzoic acid (1.02 g, 0.006 mol), thionyl chloride (10 mL), and 6 (0.87 g, 0.002 mol) according to the procedure that was used to prepare 7a, 7e (0. 
Ethyl 5-(4-(2,6-dichlorobenzyloxy)benzyl)-2-(thiophene-2-carboxamido)thiophene-3-carboxylate (7f)
By using thiophene-2-carboxylic acid (1.02 g, 0.008 mol), thionyl chloride (10 mL), and 6 (0.87 g, 0.002 mol) according to the procedure that was used to prepare 7a, 7f 
Ethyl-5-(4-(2,6-dichlorobenzyloxy)benzyl)-2-(furan-2-carboxamido)thiophene-3-carboxylate (7g)
By using furan-2-carboxylic acid (0.24 g, 0.0031 mol), thionyl chloride (5 mL), and 6 (0.91 g, 0.0021 mol) according to the procedure that was used to prepare 7a, 7g (0.47 g, 42.34%) was obtained as a yellow solid. (R f = 0. 4 To a solution of 7a (300 mg, 0.56 mmol) in EtOH (20 mL) was added 1 N NaOH (7 mL). The reaction mixture was heated to reflux for 2h. After cooling to room temperature, the reaction mixture was poured into water (50 mL) followed with 1 N HCl to pH 1. The suspension solution was extracted with EtOAc (2 x 25 mL). The combined organic layers were dried with Na 2 SO 4 and concentrated in vacuo to afford 8a. Recrystallization from AcOEt gave pure 8a (0.18 g, 64.28%) as a white solid. Mp 223-225 °C (dec 6.2 5-(4-(2,6-dichlorobenzyloxy)benzyl)-2-(4-chlorobenzamido) 
5-(4-(2,6-dichlorobenzyloxy)benzyl)-2-(2-fluorobenzamido)thiophene-3-carboxylic acid (8c)
By using 7c (0.74 g, 1.3 mmol), 1N NaOH (16 mL, 17 mol) and EtOH (20 mL) according to the procedure used to synthesize 8a, 8c (0. 
5-(4-(2,6-dichlorobenzyloxy)benzyl)-2-(2-methoxybenzamido)thiophene-3-carboxylic acid (8d)
By using 7d (0.37 g, 0.65 mmol), 1N NaOH (8.4 mL) and EtOH (20 mL) according to the procedure used to synthesize 8a, 8d (0.17 g, 48.57%) was obtained as a yellow 
5-(4-(2,6-dichlorobenzyloxy)benzyl)-2-(4-methoxybenzamido)thiophene-3-carboxylic Acid (8e)
By using 7e (0.06 g, 0.11 mmol), 1N NaOH (1.4 mL) and EtOH (20 mL) according to the procedure used to synthesize 8a, 8e (0.04 g, 67.11%) was obtained as a yellow solid. Mp 
5-(4-(2,6-dichlorobenzyloxy)benzyl)-2-(thiophene-2-carboxamido)thiophene-3-carboxylic acid (8f)
By using 7f (0.20 g, 0.37 mmol), 1N NaOH (4.8 mL) and EtOH (20 mL) according to the procedure used to synthesize 8a, 8f (0.08 g, 42.11%) was obtained as a yellow solid. 
5-(4-(2,6-dichlorobenzyloxy)benzyl)-2-(furan-2-carboxamido)thiophene-3-carboxylic acid (8g)
By using 7g (0.37 g, 0.7 mmol), 1N NaOH (9.1 mL) and EtOH (20 mL) according to the procedure used to synthesize 8a, 8g (0.20 g, 57.1%) was obtained as a yellow solid. 
5-(4-(2,6-dichlorobenzyloxy)benzyl)-2-(picolinamido)thiophene-3-carboxylic acid (8h)
By using 7h (0.24 g, 0.44 mmol), 1N NaOH (5.6 mL) and EtOH (20 mL) according to the procedure used to synthesize 8a, 8h (0. Ethyl 5-(4-(2,6-dichlorobenzyloxy)benzyl)-2-(propylamino)thiophene-3-carboxylate (9a) 1-bromopropane (0.37 g, 0.003 mol) was added to a mixture of 6 (0.65 g, 0.0015 mol), K 2 CO 3 (0.82 g, 6 mmol), and KI (100 mg) in DMF (20 mL). The resulting mixture was stirred at room temperature for 30 min and at 60 °C for a further 24h. After being cooled, the mixture was poured into ice water and the resulting mixture was extracted with AcOEt (25 mL x 2). The combined organic layers were washed with saturated brine and dried (Na 2 SO 4 ). After evaporation of the solvent in vacuo, the residue was purified by column chromatography (petroleum ether: ethyl acetate, 
Ethyl 5-(4-(2,6-dichlorobenzyloxy)benzyl)-2-(hexylamino)thiophene-3-carboxylate (9c)
By using 1-bromohexane (0.50 g, 0.003 mol), K 2 CO 3 (0.82 g, 6 mmol), KI (100 mg) and 6 (0.65 g, 0.0015 mol) in DMF (20 mL) according to the procedure that was used to prepare 9a, 9c (0.28 g, 25.90%) was obtained as a yellow oil. 10a-c   2.1.8.1. 5-(4-(2,6-dichlorobenzyloxy)benzyl)-2-(propylamino) thiophene-3-carboxylic Acid (10a)
General Procedures for the Synthesis of Compounds
To a solution of 9a (0.08 g, 0.16 mmol) in EtOH (20 mL) was added 1 N NaOH (1.9 mL, 2.1 mmol). The reaction mixture was heated to reflux for 2h. After cooling to room temperature, the reaction mixture was poured into water (50 mL) followed with 1 N HCl to pH 1. The suspension solution was extracted with AcOEt (2 x 25 mL). The combined organic layers were dried with Na 2 SO 4 
2-(butylamino)-5-(4-(2,6-dichlorobenzyloxy)benzyl)thiophene-3-carboxylic acid (10b)
By using 9b (0.06 g, 0.12 mmol), 1N NaOH (1.3 mL, 1.5 mmol) and EtOH (20 mL) according to the procedure used to synthesize 10a, 10b (0.04 g, 71.43%) was obtained as a white solid. 
Antitubercular Activity Against H37Rv (MABA)
Briefly, the test compound MICs against TB were assessed by the Microplate Alamar Blue Assay (MABA) using isoniazid, moxifloxacin , PA-824 and rifampicin (supplied by University of lllinois) as positive controls. Compound stock solutions were prepared in DMSO at a concentration of 12.8 mM, and the final test concentrations ranged from 128 to 0.5 M. Two-fold dilutions of compounds were prepared in Middlebrook 7H12 medium (7H9 broth containing 0.1% w/v casitone, 5.6 g/mL palmitic acid, 5 mg/mL bovine serum albumin, 4 mg/mL catalase, filter-sterilized) in a volume of 100 L in 96-well microplates (black viewplates). M. tuberculosis H37Rv (100 L inoculum of 2 105 cfu/mL) was added, yielding a final testing volume of 200 L. The plates were incubated at 37 °C. On the 7th day of incubation 12.5 L of 20% Tween 80 and 20 L of Alamar Blue (Trek Diagnostic, Westlake, OH) were added to the test plate. After incubation at 37 °C for 16-24 h, fluorescence of the wells was measured (ex 530, em 590 nm). The MICs were defined as the lowest concentration affecting a reduction in fluorescence of 90% relative to the mean of replicate bacteria-only controls.
RESULTS AND DISCUSSION
Chemistry
The synthetic route for preparation of new 2-amino-5-(4-(benzyloxy)benzyl)thiophene-3-carboxylic acid derivatives (8a-h and 10a-c) is summarized in (Scheme 1). The synthesis was started with reaction of commercially available 2, 6-dichlorobenzyl chloride (1) with methyl 3-(4-hydroxyphenyl)propanoate (2) to obtain the methyl 3-(4-(2,6-dichlorobenzyloxy)phenyl)propanoate (3). Reduction of 3 with NaBH 4 gave the alcohol 4 in good yield (91%). Treatment of 4 with PCC as an oxidizing agent gave the aldehyde 5 in moderate yield (73%). The key intermediate ethyl 5-(4-(2,6-dichlorobenzyloxy)benzyl)-2-aminothiophene-3-carboxylate 6 was prepared by Knovenagel condensation of aldehyde 5 with ethyl cyanoacetate followed by cyclization with elemental sulfur under basic condition (Gewald reaction [10] ). For amide series, acylation of 6 with different acyl chlorides in the presence of Et 3 N led to the desired esters 7a-h. Hydrolysis of 7a-h gave the corresponding carboxylic acids 8a-h. For amine series, treatment of 6 with various alkyl halides in DMF using K 2 CO 3 as a base gave 9a-c in moderate yields. The desired compounds 10a-c were synthesized from 9a-c following the same methodology used in the preparation of 8a-h from 7a-h.
Antitubecular Activity
All the title compounds along with the standard drugs (isoniazid, moxifloxacin, PA-824 and rifampicin) for [11, 12] (Table 1) . Compounds 8b, 8c, and 10b were found to effectively inhibit the growth of M. tuberculosis H37Rv with low micromolar MICs ( Table 1) .
In the amides, introduction of halogen substituents on the phenyl (8b and 8c) improved the antitubercular activity. Compounds 8b and 8c with p-chlorophenyl and ofluorophenyl substituent exhibited the potent activity with MIC values of 1.9 M and 7.7 M, whereas compound 8a with phenyl was less active with MIC value of 15.7 M. In contrast, introduction of electron donating group (OCH 3 ) on the phenyl ring (8d and 8e) had a detrimental effect on the inhibitory activity compared to 8b and 8c. Compounds 8f-8h, incorporated a five or six ring heterocycles, which showed moderate activity against M. tuberculosis with MICs ranging from 24.7 to 29.4 M.
In the amines, to investigate the effect of length of alkyls on activity, three compounds (10a-c) varying in length of alkyl chains were designed as displayed in Table 1 . The activity data suggested that compound 10b with four atom alkyls showed the best antitubercular activity with MIC value of 7.7 M, while the potency decreased with the decrease or increase of carbon chain (10a and 10c).
CONCLUSION
In this study, a series of 2-amino-5-(4-(benzyloxy)benzyl)thiophene-3-carboxylic acid derivatives was synthesized, and studied their antitubercular activity. All these compounds were evaluated against M. tuberculosis H37Rv and compounds 8b, 8c, and 10b exhibited potent antitubercular activity with MIC values of 1.9, 7.7 and 7.7 M, respectively. The results suggested that the compounds carrying p-chlorobenzoyl in the amides 8b and four atom alkyls in the amines 10b showed the highest activity, which were in agreement with the reported SARs from our previous studies [6] . The possible improvements in the activity can be further achieved by modifications in the substituents on 2-amino of thiophene. Therefore, compound 8b may serve as a good start to find new lead compounds against TB.
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